(Q83241116)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22244504%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

Expression of TRAIL, DR4, and DR5 in bladder cancer: correlation with response to adjuvant therapy and implications of prognosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22244504%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

Yongnan Li

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22244504%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Xiudong Jin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22244504%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Jinhua Li

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22244504%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Xinghua Jin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22244504%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Jianbo Yu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22244504%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Xiaodong Sun

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22244504%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Yanhui Chu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22244504%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Chunyan Xu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22244504%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Xiaoxia Li

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22244504%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Xijun Wang

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22244504%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Yoshiyuki Kakehi

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22244504%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Xiuxian Wu

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22244504%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

11 January 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22244504%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22244504%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22244504%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

968.e7-15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22244504%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22244504%20AND%20SRC:MED&resulttype=core&format=json

Global cancer statistics, 2002

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.011

Pathology of transitional cell carcinoma of the bladder and its clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.011

Induction of necrotic tumor cell death by TRAIL/Apo-2L.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.011

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.011

Intracellular mechanisms of TRAIL and its role in cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.011

7 January 2021

Caspases: enemies within

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.011

Tumor necrosis factor-related apoptosis-inducing ligand-mediated proliferation of tumor cells with receptor-proximal apoptosis defects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.011

MAPK/ERK overrides the apoptotic signaling from Fas, TNF, and TRAIL receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.011

Expression of TRAIL (TNF-related apoptosis-inducing ligand) and its receptors in normal colonic mucosa, adenomas, and carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.011

Prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in adjuvantly treated stage III colon cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.011

Evaluating the expression and prognostic value of TRAIL-R1 and TRAIL-R2 in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.011

Prognostic significance of Fas (CD95) and TRAIL receptors (DR4/DR5) expression in acute myelogenous leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.011

TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.011

Enhancement of TRAIL/Apo2L-mediated apoptosis by adriamycin through inducing DR4 and DR5 in renal cell carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.011

Phase 1 and Pharmacokinetic Study of Lexatumumab in Patients with Advanced Cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.011

Phase I pharmacokinetic and biologic correlative study of mapatumumab, a fully human monoclonal antibody with agonist activity to tumor necrosis factor-related apoptosis-inducing ligand receptor-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.011

Phase 2 study of mapatumumab, a fully human agonistic monoclonal antibody which targets and activates the TRAIL receptor-1, in patients with advanced non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.011

Adjuvant therapy of stage II and III colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.011

Sodium butyrate sensitizes TRAIL-mediated apoptosis by induction of transcription from the DR5 gene promoter through Sp1 sites in colon cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.011

Proteasome inhibitor MG132 upregulates death receptor 5 and cooperates with Apo2L/TRAIL to induce apoptosis in Bax-proficient and -deficient cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.011

Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.011

Evidence that the death receptor DR4 is a DNA damage-inducible, p53-regulated gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.11.011

10.1016/J.UROLOGY.2011.11.011

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22244504%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference